Orphan Drug designation

Related by string. Orphan Drug Designation * orphaned . Orphans . orphans : Little Orphan Annie . widows orphans . Swedish Orphan Biovitrum / Drugs . DRUG . drugs : Drug Task Force . Prescription Drug User Fee . Drug Enforcement Administration / designations . Designations . Designation : Fast Track designation . enemy combatant designation * Receives Orphan Drug Designation *

Related by context. All words. (Click for frequent words.) 84 Orphan Drug Designation 83 Orphan Drug status 81 orphan designation 77 Orphan Drug designations 77 Orphan Drug Status 76 orphan drug 76 Fast Track Status 76 Orphan designation 75 Orphan Designation 75 Orphan Status 74 Orphan Medicinal Product 74 Fast Track Designation 74 OMP designation 74 orphan medicinal product 72 FDA Orphan Drug 70 Application MAA 70 Fast Track designation 70 Orphan Drug 70 Granted Orphan Drug 69 Marketing Authorization 69 Marketing Authorisation 69 Receives Orphan Drug Designation 69 granted orphan 68 Marketing Authorisation Application 68 Fast Track designations 68 TEMODAL 68 Civacir 67 Positive Opinion 67 GTC recombinant human 67 Priority Review 67 Cellegesic 67 ATryn R 67 Firazyr 67 Medicinal Products EMEA 67 Evoltra ® 67 Preotact R 67 Receives Marketing Authorization 67 ATryn ® 67 Amrubicin 67 Preotact 67 Loramyc R 67 Receives Fast Track 66 Receives Orphan Drug 66 Somatuline Depot 66 Mimpara 66 SYCREST 66 Ceflatonin 66 Icatibant 66 Tostrex 66 Mutual Recognition Procedure 66 SNT MC# 66 Retacrit 66 Raptiva ® 66 Trobalt 65 Mepact 65 Evoltra 65 Zenpep 65 Torisel 65 Plenaxis R 65 GTC recombinant form 65 BYETTA ® 65 SEBIVO 65 Receives Positive Opinion 65 liver resection surgeries 65 methylnaltrexone 65 Patent Covering 65 Loramyc ® 65 R bendamustine hydrochloride 65 Nexavar ® 65 acetonide FA 65 rilonacept 65 XIAPEX ® 64 COLAZAL R 64 vapreotide acetate 64 Syndrome LEMS 64 granted Orphan Drug 64 ELIQUIS 64 RELISTOR ® 64 Advagraf 64 rasagiline tablets 64 Personalized Immunotherapy 64 Raptiva R 64 Abstral ® 64 Ciclesonide 64 Peginterferon alfa 2b 64 Loramyc ™ 64 Marketing Authorization Application 64 Abstral 64 Sanvar R 64 Yondelis ® 64 Kepivance 64 FOLOTYN ® 64 Soliris TM eculizumab 64 Alvesco R 64 histamine dihydrochloride 64 Vandetanib 64 Iluvien ® 64 granted orphan medicinal 64 oncology indications 64 Aviptadil 63 Actemra tocilizumab 63 Febuxostat 63 Fludara ® 63 Meets Primary Endpoint 63 Zalbin 63 Zorbtive TM 63 Panzem R 63 Campath alemtuzumab 63 drug ISA# 63 Product Designation 63 Aloxi R 63 Uplyso 63 XIAPEX 63 Gleevec Glivec 63 Campath ® 63 Bendamustine 63 Pirfenidone 63 Lambert Eaton Myasthenic 63 Noxafil 63 Vidaza R 63 Pivotal Phase III 63 GVAX cancer 63 RoACTEMRA 63 Completes Patient Enrollment 63 Friedreich Ataxia FRDA 63 CIMZIA r 63 Nivestim 63 FDA Accepts 63 Onconase 63 MyVax R 63 Evoltra TM 63 FIRAZYR 63 Rapinyl 63 Cloretazine ® 63 Entocort 63 REBETOL combination therapy 63 Arzerra ofatumumab 63 Kuvan R 63 Movectro 63 Junovan TM 63 Nabi HB Intravenous 63 Intravenous CP 63 Initiates Enrollment 63 nasal calcitonin product 63 refractory chronic lymphocytic 63 Evoltra R 63 Gamunex C 63 PecFent 63 Hexvix ® 63 Archexin 63 Sensipar R 63 BENLYSTA ® 63 Tarceva TM 63 neovascular age 63 CryoSeal FS System 63 PGL# 63 TNF Tumor Necrosis Factor 63 liposomal formulation 63 sorafenib tablets 63 ONCASPAR 63 Modrenal R 63 YONDELIS 63 Jevtana 63 davunetide 63 methylnaltrexone bromide 63 P#X# antagonist 63 MOVIPREP R 63 Expanded Indication 62 Certican 62 Increlex R 62 targeted radiotherapeutic 62 JOULFERON 62 Zenvia ™ 62 CONBRIZA 62 Octreolin 62 acyclovir Lauriad R 62 Adenuric R 62 Accelerated Approval 62 amrubicin 62 Thrombin topical Recombinant 62 PNP inhibitor 62 Tetrabenazine 62 Sumatriptan Succinate 62 Oracea ® 62 MAGE A3 ASCI 62 Taxotere docetaxel 62 Intravenous Human 62 ATryn ® GTC recombinant 62 Nabi HB R 62 Cimzia certolizumab pegol 62 Multiferon 62 Keppra ® XR 62 Degarelix 62 Aryplase 62 Argatroban 62 Files IND 62 topical NSAID 62 Nexavar sorafenib 62 generation purine nucleoside 62 levocetirizine 62 Tibotec Therapeutics division 62 submitted Marketing Authorization 62 TREANDA 62 miconazole Lauriad R 62 VISICOL R 62 oropharyngeal candidiasis 62 Gleevec imatinib mesylate 62 OMAPRO ™ 62 Alvesco ® 62 ACOMPLIA R 62 taliglucerase alfa 62 Rebif ® 62 Gleevec imatinib 62 MEZAVANT 62 European Marketing Authorizations 62 Factor VIIa 62 Pfizer Sutent 62 novel histone deacetylase 62 CIP TRAMADOL ER 62 ZADAXIN ® 62 Bafetinib 62 Initiates Phase III 62 Zebinix R 62 Keppra ® levetiracetam 62 Avastin bevacizumab 62 subsidiaries visit http:/www.apricusbio.com 62 etanercept Enbrel 62 CAMPATH R 62 R sorafenib tablets 62 Marqibo TM 62 Biologic License Application BLA 62 Phase III Clinical Trial 62 Zavesca r 62 Nebido 62 ZALBIN 62 ocular formulation 62 DC Bead 62 Everolimus 62 Sutent sunitinib 62 Decentralized Procedure 62 Glybera R 62 Loramyc 62 Nimotuzumab 62 Xanafide 62 Marketing Authorization Applications 62 USFDA approval 62 Application BLA 62 novel oral anticoagulant 62 Ixempra 62 Removab 62 XIAFLEX ™ 62 cinacalcet HCl 62 tamibarotene 62 Alitretinoin 62 ISENTRESS raltegravir 62 Thalidomide Pharmion 62 PDE4 inhibitor 62 receptor tyrosine kinase inhibitor 62 RANK Ligand inhibitor 61 BENLYSTA 61 Silodosin 61 motexafin gadolinium Injection 61 SUMAVEL DosePro 61 ankylosing spondylitis psoriatic arthritis 61 Orapred ODT 61 silodosin 61 Drug Eluting Stent System 61 RhuDex ® 61 TAXUS Element Paclitaxel Eluting 61 Marketing Authorization Application MAA 61 subcutaneous formulation 61 anticancer compound 61 REVLIMID lenalidomide 61 Esbriet ® 61 clofarabine 61 Cimzia ® certolizumab pegol 61 Cladribine 61 DPP4 inhibitor 61 aerosolized AAT 61 Kit CD# positive 61 Hycamtin 61 Esbriet pirfenidone 61 Bayer Nexavar 61 Liprotamase 61 IL# PE#QQR 61 Neulasta R 61 European Medicines Evaluation 61 rheumatoid arthritis psoriatic arthritis 61 Telzir 61 LUCASSIN 61 Loramyc TM 61 molecular imaging radiopharmaceutical 61 successfully commercialize Iluvien 61 Sebivo 61 Eligard R 61 #D#C# 61 Initiate Clinical Trial 61 Allovectin 7 61 Alfa Wassermann 61 rotigotine transdermal patch 61 Urocidin 61 Romiplostim 61 Emezine 61 Proquin XR 61 solifenacin succinate 61 ZEFTERA TM Zevtera TM 61 NerPharMa 61 immunotherapeutic vaccine 61 TORISEL 61 eltrombopag 61 Soliris eculizumab 61 Maribavir 61 Announces Tentative Approval 61 Promacta 61 Apricus Bio 61 Initiates Phase II 61 Afinitor ® 61 Brilique 61 Opterone R 61 Grants Orphan Drug 61 ALVESCO R 61 Biologics License Application 61 Nexavar tablets 61 Abiraterone acetate 61 Crofelemer budesonide foam 61 pregabalin Lyrica 61 Fortical R 61 IV acetaminophen 61 Albugon 61 MAA submission 61 Marketing Authorisation Application MAA 61 supplemental Biologics License Application 61 ALN PCS 61 oral taxane 61 Vitrasert R 61 Genasense ® 61 Votrient 61 dirucotide MBP# 61 Pazopanib 61 Fresenius Biotech 61 StaphVAX R 61 Traficet EN 61 ADP receptor antagonist 61 UPLYSO 61 Serostim ® 61 Ceflatonin R 61 IMiDs ® 61 Sylvie Gregoire President 61 Combidex 61 Angiox 61 Rituxan rituximab 61 Dynepo 61 Initiates Clinical Trial 61 Epratuzumab 61 NEBIDO R 61 Receives Approvable Letter 61 TORISEL TM 61 PROMACTA 61 Clevudine 61 OMNARIS HFA 61 induced macular edema 61 relapsing forms 61 AMITIZA lubiprostone 61 Cladribine Tablets 61 Humira adalimumab 61 commercialize oritavancin 61 IRESSA 61 BiovaxID TM 61 Glassia 61 Investigational Device Exemption 61 submitted Biologics License 61 POSIDUR ™ 61 Pafuramidine 61 Ranexa R 61 RoActemra 61 Tyverb 61 Project QTDP program 61 histone deacetylase HDAC inhibitor 61 Zingo TM 61 ixabepilone 61 Arimoclomol 60 Veregen R 60 Onalta ™ 60 Japanese Encephalitis Vaccine 60 LymphoStat B belimumab 60 human antithrombin 60 post menopausal osteoporosis 60 atacicept 60 Wafer polifeprosan 60 rufinamide 60 FRDA 60 Irinotecan 60 HuMax TAC 60 forodesine 60 omacetaxine mepesuccinate 60 markets HP Acthar 60 CHMP recommendation 60 Onsolis 60 oral prodrug 60 Onco TCS 60 Revolade 60 Patent Broadly Covering 60 REMICADE infliximab 60 FDA APPROVES 60 Mylan Receives Approval 60 Release Capsules 60 Dupuytren Contracture 60 ospemifene 60 Fibrillex TM 60 Arranon 60 Fodosine 60 Zegerid OTC 60 FDA Clearance 60 highly purified pasteurized 60 5 lipoxygenase inhibitor 60 Gendux 60 Zirgan 60 Catena ® 60 XIAFLEX ® 60 registrational studies 60 FIRMAGON R 60 Centralized Procedure 60 BRILINTA 60 HepaSphere 60 Vascular Wrap TM 60 everolimus tablets 60 XAGRID 60 Firdapse ™ amifampridine phosphate 60 Increlex ® 60 Onalta 60 novel VDA molecule 60 MEPACT 60 Aloxi ® 60 Emselex 60 Eribulin 60 PREOS R 60 TELINTRA 60 RAPTIVA 60 Submits Response 60 Genasense R 60 Daclizumab 60 KNS # 60 OLEPTRO 60 oral ridaforolimus 60 Somatuline R Autogel R 60 Multiferon R 60 markets Gelclair R 60 miconazole Lauriad 60 Patients Treated With 60 MERREM 60 interferon gamma 1b 60 TheraCIM 60 YONDELIS R 60 Files Investigational 60 Firdapse 60 IMiDs ® compound 60 CE Marked 60 Neupro R 60 Granulocyte Colony Stimulating Factor 60 Carbidopa 60 thetreatment 60 mertansine 60 ATG Fresenius S 60 FDA Approvable Letter 60 SUTENT ® 60 vinorelbine emulsion 60 Octreotide 60 PEGylated anti 60 XIAFLEX TM 60 Satraplatin 60 Sycrest 60 Etravirine 60 Clolar ® 60 granted Orphan Designation 60 Ambrisentan 60 Filgrastim 60 idursulfase 60 docetaxel Taxotere ® 60 ONGLYZA ™ 60 Orazol 60 sapropterin dihydrochloride 60 Torisel temsirolimus 60 Orencia abatacept 60 desvenlafaxine 60 HIV protease inhibitor 60 cyclobenzaprine hydrochloride extended 60 sublingual tablets 60 Lumacan 60 please visit www.innercool.com 60 IMiD 60 vemurafenib 60 Recombinant Human 60 PrevOnco ™ 60 HuMax CD4 60 Li Fraumeni Syndrome 60 Combination REOLYSIN R 60 Azedra 60 Inhalation Aerosol 60 Cethrin 60 commercialize telaprevir 60 Ganite ® 60 Somatuline Autogel 60 orally administered inhibitor 60 Orphan Drugs 60 Relistor 60 cutaneous T 60 Cancidas 60 Government Qualifying Therapeutic 60 BEMA ® 60 QVAR 60 HepaGam B 60 Simulect 60 ELAPRASE 60 Development OOPD 60 Mycamine 60 palonosetron 60 NOXAFIL 60 Advexin 60 Initiates Clinical 60 VPRIV 60 SANVAR 60 BioSTAR R 60 treat opioid induced 60 IMiDs 60 ADVEXIN p# therapy 60 MabCampath 60 Phase IIb Trial 60 DepoDur 60 Romidepsin 60 Campto 60 tolperisone 60 Golimumab 60 Vitaros ® 60 Leukine ® 60 Fortigel 60 delivers fluocinolone acetonide FA 60 formerly LymphoStat B 60 UCB Keppra 60 intravenous acetaminophen 60 oral cladribine 60 Receives Milestone Payment 60 Hexvix 60 alvimopan 60 SEASONALE R 60 Mirapexin 60 Expedited Review 60 SomatoKine 60 Clofarabine 60 severe hypercholesterolemia 60 Submits NDA 60 Submits Biologics License Application 60 Insegia 60 AVASTIN 60 lintuzumab SGN 60 Vpriv 60 Phase IIIb clinical 59 EOquin 59 GA GCB 59 developing Bicifadine serotonin 59 opioid induced constipation OIC 59 TRANSDUR ™ 59 CIP Fenofibrate 59 Ganciclovir 59 equine osteoarthritis 59 Metformin HCl 59 RAPAFLO 59 Xeloda ® 59 Vidaza azacitidine 59 ZEVALIN ® 59 relapsing multiple sclerosis 59 Increlex TM 59 NDA Submission 59 miconazole Lauriad ® 59 beta 1a 59 LymphoStat B TM 59 LHRH antagonist 59 Methylphenidate Transdermal System 59 Juvantia 59 RECOTHROM ® 59 Impax ANDA 59 proteasome inhibitor 59 Lucanix R 59 Lenalidomide 59 LEVADEX ™ 59 investigational antiplatelet agent 59 FACTIVE R gemifloxacin 59 Qualifying Therapeutic Discovery 59 photoprotective drug 59 BARACLUDE R 59 TAXUS Element Stent System 59 intranasal formulation 59 AAG geldanamycin analog 59 amifampridine phosphate 59 Azilect ® 59 Alemtuzumab 59 refractory acute promyelocytic 59 afamelanotide 59 Psoriasis Drug 59 TRISENOX ® 59 BEMA Fentanyl 59 recombinant interferon 59 reslizumab 59 Teysuno 59 AMEVIVE 59 Serdolect ® 59 ThermoDox R 59 Prestara 59 Omacor ® 59 severe gastroparesis 59 DosePro TM 59 eprodisate KIACTA TM 59 Behcet uveitis 59 Xyrem ® 59 tetrabenazine 59 Nexavar prescribing 59 OHR/AVR# 59 dextromethorphan quinidine 59 thalidomide Thalomid 59 Frova ® 59 Teflaro 59 Reports Preclinical Data 59 Eloxatin ® 59 Isavuconazole 59 Troxatyl 59 CCR5 antagonist 59 pitavastatin 59 Junovan 59 Anthim 59 FUSILEV ® 59 Basilea Toctino R 59 Fingolimod 59 Demonstrates Significant 59 NeoVisc ® 59 ABILIFY ® 59 injectable formulation 59 Cx# [002] 59 SPL# Gel vaginal microbicide 59 lexidronam injection 59 Drug Candidate 59 Ceplene histamine dihydrochloride 59 Troxatyl TM 59 PLK1 SNALP 59 oxaliplatin Eloxatin 59 metastatic hormone refractory 59 adalimumab Humira 59 lucinactant 59 Tezampanel 59 pediatric Crohn disease 59 trade name Normix 59 aldehyde dehydrogenase ALDH2 deficiency 59 Tracleer r 59 personalized cellular immunotherapy 59 Oracea TM 59 SUMAVEL 59 thymalfasin 59 mesylate tablets 59 tafamidis 59 topically applied SEPA 59 IMA# 59 AMITIZA R 59 Dapagliflozin 59 Doripenem 59 Valtropin 59 Australian Therapeutic Goods 59 POSIDUR TM ELADUR TM 59 Risperidone Oral Solution 59 Unit Dose Budesonide 59 Glatiramer Acetate 59 Rapydan 59 Temodar ® 59 Ilaris 59 Azilect R 59 Saizen ® 59 ALN TTR 59 Diamyd ® 59 1mg tablets 59 Oral Spray 59 IAP inhibitor 59 Etanercept 59 Iluvien TM 59 Pemetrexed 59 GATTEX TM 59 PHX# 59 Lodotra 59 Lenocta 59 Eraxis 59 Onbrez Breezhaler 59 Microplasmin 59 chimeric monoclonal antibody 59 Darunavir 59 recombinant biopharmaceutical 59 sitaxsentan sodium 59 TH# [003] 59 mesylate 59 CLIA waiver 59 prGCD 59 Ceplene 59 NUEDEXTA ™ 59 pseudobulbar affect PBA 59 TroVax ® 59 GW# [003] 59 mitogen activated ERK kinase 59 acting muscarinic antagonist 59 Viviant 59 initiated Phase Ib 59 DAVANAT ® 59 GlaxoSmithKline Tykerb 59 Maraviroc 59 Prodarsan R 59 AMITIZA ® 59 hoFH 59 Resolor 59 LEUKINE 59 Nasdaq VNDA 59 VIVITROL ® 59 Pixantrone 59 Sancuso 59 Rhucin ® recombinant 59 herpetic keratitis 59 Dabigatran etexilate 59 Phenoptin 59 TRANSDUR ® 59 SFDA approval 59 Dyloject TM 59 prokinetic agent 59 Vitaros 59 KIACTA ™ 59 SURFAXIN 59 THALOMID 59 Brinavess 59 Zelrix 59 PrevOnco 59 application sNDA 59 Bayer Onyx 59 Tramadol ER 59 RECOTHROM R 59 Phase 2b Clinical Trial 59 diabetic neuropathic pain 59 R rilonacept Injection 59 Angiox R 59 dasatinib Sprycel ® 59 Oxaliplatin 59 metaglidasen 59 Initiates Clinical Trials 59 Axentis Pharma 59 Neovastat 59 fludarabine phosphate 59 oropharyngeal candidiasis OPC 59 DPX Survivac 59 2 inhibitor CYT# 59 Supplemental Biologics License Application 59 Remicade infliximab 59 Qualified Therapeutic Discovery 59 Aurexis 59 Topotecan 59 Herceptin trastuzumab 59 Arcalyst 59 Methylnaltrexone 59 AZILECT R 59 CYT# potent vascular disrupting 59 alefacept 59 NeuroSTAT ® 59 AzaSite Xtra 59 Rasagiline 59 Vimpat ® lacosamide 59 abiraterone acetate 59 investigational pharmacologically unique 59 ONSOLIS 59 DNA demethylating agent 59 Dacogen injection 59 Lovaza TM 59 Captisol enabled 59 SUPPRELIN R LA 59 Bronchitol 59 Azacitidine 59 Erwinase 59 EPCT 59 Allovectin 7 R 59 Bezielle 59 palifermin 59 BioDelivery Sciences Announces 59 Increlex 59 Fenoglide 59 selective A2A adenosine receptor 59 donepezil hydrochloride 59 volociximab 59 Wyeth Torisel 59 Biological License Application 59 pediatric exclusivity 59 InterfeRx 59 Vasovist 59 intravenous AAT 59 Rifaximin 59 Orally administered 59 HFA MDI 59 octreotide acetate 59 albinterferon alfa 2b 59 terlipressin 59 multiple myeloma MM 59 Orathecin 59 OvaRex ® MAb 59 TRISENOX R 59 ENTEREG ® 59 briakinumab 59 casopitant 59 systemic immunosuppressive drugs 59 prostone 59 anti inflammatory NSAID 59 metastatic castrate resistant 59 Fanapt ™ 59 Phase #b/#a clinical 58 Merz Pharmaceuticals 58 Vectibix panitumumab 58 R lenalidomide 58 Ceflatonin ® 58 synthetic peptide containing 58 aripiprazole Abilify 58 hypereosinophilic syndrome 58 Aflibercept 58 Ceplene R 58 Xcytrin R 58 GEM #S 58 Pathway Inhibitor 58 HIV integrase inhibitor 58 targeting CD# 58 wilate ® 58 vitreoretinal disorders 58 Plenaxis TM 58 SinuNase TM 58 sBLA 58 Voraxaze 58 Prodarsan ® 58 Forsteo 58 Synerx Pharma 58 fostamatinib 58 received CE Marking 58 Hsp# Inhibitor 58 Patient Enrolment 58 MPS VI 58 hyaluronidase enzyme 58 Betaseron ® 58 prasterone 58 huC# DM4 58 Vicinium TM 58 Milestone Payments 58 Belimumab 58 dihydrochloride 58 Pennsaid R 58 Halaven 58 Vfend 58 fipamezole 58 investigational therapies 58 tiapamil 58 ATPace TM 58 BEXXAR 58 GRALISE 58 PROVENGE ® 58 IPLEX 58 Plicera 58 No Objection Letter 58 DORIBAX 58 Rectogesic 58 ketolide antibiotic 58 Million Milestone Payment 58 Clinical Trial Application 58 investigational humanized monoclonal antibody 58 OvaRex R 58 small molecule Hedgehog 58 Xolegel 58 Cefprozil tablets 58 Striant 58 radiotherapeutic 58 Investigational Compound 58 Morquio 58 BEMA TM Fentanyl 58 arsenic trioxide injection 58 cell lymphoma CTCL 58 Pivotal Trial 58 novel synthetic PEGylated 58 Lupuzor 58 registrational trial 58 Sprycel dasatinib 58 R Saizen R 58 Omapro 58 STELARA TM 58 ruxolitinib 58 Milestone Payment From 58 Rebif interferon beta 1a 58 candidate TNFerade biologic 58 XIFAXAN R 58 Project QTDP 58 ULTRASE 58 Renvela ® 58 PhosLo R 58 Mimpara R 58 highly selective adenosine 58 Norgine BV 58 Tasimelteon 58 VALSTAR 58 Surfaxin LS 58 Ganite R 58 Bucindolol 58 BRAF inhibitor 58 Fluconazole 58 INSPIRE Trial Phase III 58 Eluting Coronary Stent System 58 Revlimid lenalidomide 58 thrombolytic agent 58 Vilazodone 58 Cellegesic TM nitroglycerin ointment 58 Intravenous Hepatitis B 58 Navelbine ® 58 ADVEXIN 58 relapsing remitting MS RRMS 58 candidates Azedra TM 58 Immune Globulin Human 58 JAK inhibitor 58 Marketing Authorizations 58 Eliquis 58 Pradefovir 58 pralatrexate injection folate analogue 58 Ridaforolimus 58 IMiDs R 58 Release Tablets 58 Investigational Treatment 58 Kuvan 58 sorafenib Nexavar 58 Tocilizumab 58 Esbriet 58 valtorcitabine 58 Sumavel DosePro 58 Tarceva erlotinib 58 Pivotal Phase 58 TYZEKA 58 NanoTab 58 sunitinib malate 58 AMRIX 58 Ceplene ® histamine dihydrochloride 58 Rhucin R 58 Tigecycline 58 chronic idiopathic thrombocytopenic purpura 58 Solasia 58 Cetrorelix 58 immunotherapies 2A/Furin 58 dasatinib Sprycel 58 Mycograb 58 AA amyloidosis 58 Syncria 58 Tesamorelin 58 phase IIb clinical 58 BREAKYL 58 Neuromodulation System 58 CINTREDEKIN BESUDOTOX 58 Submits Supplemental 58 Levoleucovorin 58 CINOD 58 R adalimumab 58 Swissmedic 58 IFN Beta CTP 58 candidate Zenvia 58 XGEVA 58 Bevacizumab 58 rxRNA 58 FOSRENOL 58 Preclinical studies suggest 58 GLASSIA ™ 58 Pyridorin 58 phase III isavuconazole 58 Besivance 58 THELIN 58 mild vasodilator 58 Vantas 58 diarrhea predominant irritable 58 docetaxel Taxotere R 58 lorvotuzumab mertansine 58 HQK 58 LUVENIQ 58 anthrax monoclonal antibody 58 alfa 2a 58 Aceon 58 Generic Version 58 buccal spray 58 CE Marking 58 RESOLOR 58 PEGylated Fab fragment 58 License Application sBLA 58 small molecule thrombopoietin 58 pain palliation 58 OncoGel 58 inhalation powder 58 CE IVD 58 UCB Cimzia 58 psoriasis rheumatoid arthritis 58 Ceplene TM 58 Firazyr ® 58 Safinamide 58 Novel Oral 58 TRX1 58 Testosterone Gel

Back to home page